Bristol-Myers Squibb Company
BMY
$60.66
$0.360.60%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.29% | -0.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.29% | -0.38% | |||
| Cost of Revenue | 5.89% | -1.31% | |||
| Gross Profit | 0.95% | -0.03% | |||
| SG&A Expenses | 16.72% | 5.86% | |||
| Depreciation & Amortization | -0.60% | 0.12% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.38% | 2.79% | |||
| Operating Income | -8.74% | -6.63% | |||
| Income Before Tax | -52.79% | 75.73% | |||
| Income Tax Expenses | -58.22% | 99.78% | |||
| Earnings from Continuing Operations | -50.52% | 67.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -83.33% | 400.00% | |||
| Net Income | -50.61% | 68.02% | |||
| EBIT | -8.74% | -6.63% | |||
| EBITDA | -7.40% | -4.18% | |||
| EPS Basic | -50.61% | 67.94% | |||
| Normalized Basic EPS | -5.18% | -3.28% | |||
| EPS Diluted | -50.97% | 68.75% | |||
| Normalized Diluted EPS | -5.27% | -3.28% | |||
| Average Basic Shares Outstanding | 0.00% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.10% | 0.05% | |||
| Dividend Per Share | 1.61% | 0.00% | |||
| Payout Ratio | 1.02% | -0.40% | |||